Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pfenex Inc (PFNX)

Pfenex Inc (PFNX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 389,615
  • Shares Outstanding, K 31,676
  • Annual Sales, $ 14,860 K
  • Annual Income, $ -39,590 K
  • 60-Month Beta 2.30
  • Price/Sales 12.20
  • Price/Cash Flow N/A
  • Price/Book 7.09

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.05
  • Number of Estimates 1
  • High Estimate 0.05
  • Low Estimate 0.05
  • Prior Year -0.22
  • Growth Rate Est. (year over year) +122.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.54 +16.70%
on 01/02/20
13.95 -11.83%
on 01/16/20
-0.38 (-3.00%)
since 12/17/19
3-Month
8.41 +46.20%
on 11/19/19
13.95 -11.83%
on 01/16/20
+3.40 (+38.20%)
since 10/17/19
52-Week
3.40 +261.76%
on 01/29/19
13.95 -11.83%
on 01/16/20
+8.30 (+207.50%)
since 01/17/19

Most Recent Stories

More News
Pfenex Inc Up 23.1% Since SmarTrend Uptrend Call (PFNX)

SmarTrend identified an Uptrend for Pfenex Inc (AMEX:PFNX) on December 2nd, 2019 at $10.27. In approximately 1 month, Pfenex Inc has returned 23.08% as of today's recent price of $12.64.

PFNX : 12.30 (-1.76%)
Serum Institute of India Private Limited has achieved World Health Organization (WHO) prequalification for PNEUMOSIL(R), containing CRM197 produced in Pfenex Expression Technology

Pfenex Inc. (NYSE American: PFNX) today announced that Serum Institute of India Private Limited (Serum Institute) achieved World Health Organization (WHO) prequalification for Pneumosil, a 10-valent pneumococcal...

PFNX : 12.30 (-1.76%)
SmarTrend Watching for Potential Rebound in Shares of Pfenex Inc After 1.89% Loss

Pfenex Inc (AMEX:PFNX) traded in a range yesterday that spanned from a low of $11.04 to a high of $11.34. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $11.23 on...

PFNX : 12.30 (-1.76%)
Look for Shares of Pfenex Inc to Potentially Rebound after Yesterday's 3.85% Sell Off

Pfenex Inc (AMEX:PFNX) traded in a range yesterday that spanned from a low of $11.45 to a high of $12.00. Yesterday, the shares fell 3.8%, which took the trading range below the 3-day low of $12.25 on...

PFNX : 12.30 (-1.76%)
Pfenex Earns $15 Million Development Milestone Under its Development and License Agreement With Jazz Pharmaceuticals

Pfenex Inc. (NYSE American: PFNX) today announced that it has earned a $15 million development milestone under its development and license agreement with Jazz Pharmaceuticals plc. The milestone is associated...

PFNX : 12.30 (-1.76%)
19.1% Return Seen to Date on SmarTrend Pfenex Inc Call (PFNX)

SmarTrend identified an Uptrend for Pfenex Inc (AMEX:PFNX) on December 2nd, 2019 at $10.27. In approximately 2 weeks, Pfenex Inc has returned 19.08% as of today's recent price of $12.23.

PFNX : 12.30 (-1.76%)
Shares of Adamas Pharmaceu Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (ADMS , PFNX, MNTA , SPPI , BLUE )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

ADMS : 5.88 (-0.34%)
MNTA : 30.60 (+1.76%)
PFNX : 12.30 (-1.76%)
Tg Therapeutics has the Best Relative Performance in the Biotechnology Industry (TGTX , CYTK , DVAX , MRTX, PFNX)

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

CYTK : 12.14 (-3.73%)
DVAX : 6.03 (-2.27%)
TGTX : 13.70 (-2.35%)
MRTX : 97.05 (-0.39%)
PFNX : 12.30 (-1.76%)
Pfenex Inc Set to Possibly Pullback After Yesterday's Rally of 2.74%

Pfenex Inc (AMEX:PFNX) traded in a range yesterday that spanned from a low of $11.11 to a high of $11.76. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $11.01...

PFNX : 12.30 (-1.76%)
Pfenex to Present at the Piper Jaffray 31st Annual Healthcare Conference

Pfenex Inc. (NYSE American: PFNX) is a development and licensing biotechnology company focused on leveraging its PfÄ"nex Expression Technology(R) to develop and improve protein therapies for unmet patient...

PFNX : 12.30 (-1.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade PFNX with:

Business Summary

Pfenex Inc. is a clinical-stage biotechnology company developing and commercializing proteins. The company's lead product candidate is PF582, a biosimilar candidate to Lucentis, for the potential treatment of patients with retinal diseases. It leverages its Pf'nex Expression Technology (TM) platform...

See More

Key Turning Points

2nd Resistance Point 13.11
1st Resistance Point 12.70
Last Price 12.30
1st Support Level 11.99
2nd Support Level 11.69

See More

52-Week High 13.95
Last Price 12.30
Fibonacci 61.8% 9.92
Fibonacci 50% 8.68
Fibonacci 38.2% 7.43
52-Week Low 3.40

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar